Company: IXHL
Filing Date: 2025-03-18
Form Type: PRE 14A
Source: 0001213900-25-024754
Chunk: 30

Company: Incannex Healthcare Inc.
Filing Date: 2025-03-18
Form: PRE 14A
Chunk 30
---
 on this proposal. Brokerage
firms do not have authority to vote customers’ unvoted shares held by the firms in street name on this proposal.

THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE TO APPROVE THE ADJOURNMENT PROPOSAL. PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR OF THE PROPOSAL UNLESS A STOCKHOLDER INDICATES OTHERWISE ON ITS PROXY CARD OR VOTING INSTRUCTION FORM.

<div align='center'>17

OTHER MATTERS</div>

Our board of directors knows
of no other business which will be presented to the Special Meeting. If any other business is properly brought before the Special Meeting,
proxies will be voted in accordance with the judgment of the persons named therein.

<div align='center'>STOCKHOLDER PROPOSALS AND
NOMINATIONS FOR DIRECTOR</div>

To be considered for inclusion
in the proxy statement relating to our 2025 annual meeting of stockholders, we must receive stockholder proposals (other than for director
nominations) no later than July 15, 2025. To be considered for presentation at such annual meeting, although not included in the proxy
statement, proposals (including director nominations that are not requested to be included in our proxy statement) must be received no
later than the close of business on the 90th day nor earlier than the close of business on the 120th day prior to the first anniversary
of the preceding year’s annual meeting, or if no annual meeting was held in the preceding year, notice by the stockholder to be
timely must be so delivered not earlier than the close of business on the 120th day prior to such annual meeting and not later than the
close of business on the later of the 90th day prior to such annual meeting or the 10th day following the date on which public announcement
of the date of such meeting is first made. In addition to satisfying the foregoing advance notice requirements, to comply with the universal
proxy rules under the Securities Exchange Act of 1934 (the “Exchange Act”), stockholders who intend to solicit proxies in
support of director nominees other than Incannex Healthcare Inc.’s nominees must follow the requirements set forth in Rule 14a-19
as promulgated under the Exchange Act.

Proposals that are not received
in a timely manner or in accordance with applicable law will not be voted on at the annual meeting of stock